Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

Cervical dystonia (CD) is primarily treated with botulinum toxin, at intervals of ≥ 12 weeks. We present efficacy, patient-reported outcomes (PROs), and safety in adults with CD at the last available visit after a single set of abobotulinumtoxinA (aboBoNT-A) injections versus placebo using 500 U in...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Atul T., Lew, Mark F., Dashtipour, Khashayar, Isaacson, Stuart, Hauser, Robert A., Ondo, William, Maisonobe, Pascal, Wietek, Stefan, Rubin, Bruce, Brashear, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850472/
https://www.ncbi.nlm.nih.gov/pubmed/33524060
http://dx.doi.org/10.1371/journal.pone.0245827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850472/
https://www.ncbi.nlm.nih.gov/pubmed/33524060
http://dx.doi.org/10.1371/journal.pone.0245827

Ejemplares similares